Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2013
Cargando información sobre las referencias
The goal of this clinical research study is to learn if eltrombopag can help to control MDS. The safety of this drug will also be studied.
Epistemonikos ID: 266c74c5347a579f2b020b3b2df12c30c3020816
First added on: May 11, 2024